Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Cash Flow Reinvestment Rate
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow Reinvestment Rate of 1.20x as of September 2025, reinvesting CN¥41.69 Million (capex CN¥41.69 Million ) from operating cash flow of CN¥34.69 Million. Check Tibet Cheezheng Tibetan Medicine Co Ltd (002287) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Tibet Cheezheng Tibetan Medicine Co Ltd across 19 annual periods. Explore 002287 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Tibet Cheezheng Tibetan Medicine Co Ltd. For live market cap and broader valuation context, see how much is Tibet Cheezheng Tibetan Medicine Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥326.76 Million | CN¥729.70 Million | CN¥153.08 Million | ▼ -60.5% |
| 2024 | 1.13x | CN¥518.02 Million | CN¥456.75 Million | CN¥255.44 Million | ▲ +153.2% |
| 2023 | 0.45x | CN¥310.63 Million | CN¥693.41 Million | CN¥234.81 Million | ▼ -64.9% |
| 2022 | 1.28x | CN¥364.96 Million | CN¥285.69 Million | CN¥272.40 Million | ▼ -37.3% |
| 2021 | 2.04x | CN¥2.11 Billion | CN¥1.03 Billion | CN¥125.57 Million | ▼ -20.0% |
| 2020 | 2.55x | CN¥608.22 Million | CN¥238.65 Million | CN¥338.97 Million | ▲ +123.8% |
| 2019 | 1.14x | CN¥462.27 Million | CN¥405.95 Million | CN¥52.27 Million | ▲ +327.3% |
| 2018 | 0.27x | CN¥133.09 Million | CN¥499.40 Million | CN¥128.94 Million | ▼ -78.7% |
| 2017 | 1.25x | CN¥287.13 Million | CN¥229.83 Million | CN¥66.13 Million | ▲ +72.9% |
| 2016 | 0.72x | CN¥281.15 Million | CN¥389.20 Million | CN¥179.87 Million | ▼ -6.1% |
| 2015 | 0.77x | CN¥198.24 Million | CN¥257.81 Million | CN¥64.90 Million | ▲ +193.5% |
| 2014 | 0.26x | CN¥81.48 Million | CN¥310.95 Million | CN¥81.48 Million | ▼ -30.1% |
| 2013 | 0.37x | CN¥74.38 Million | CN¥198.48 Million | CN¥74.38 Million | ▲ +3.1% |
| 2012 | 0.36x | CN¥61.65 Million | CN¥169.67 Million | CN¥61.65 Million | ▼ -38.6% |
| 2010 | 0.59x | CN¥57.32 Million | CN¥96.91 Million | CN¥57.32 Million | ▲ +531.7% |
| 2009 | 0.09x | CN¥16.44 Million | CN¥175.58 Million | CN¥16.44 Million | ▼ -74.1% |
| 2008 | 0.36x | CN¥23.79 Million | CN¥65.93 Million | CN¥23.79 Million | ▲ +8.2% |
| 2007 | 0.33x | CN¥30.49 Million | CN¥91.43 Million | CN¥30.49 Million | ▼ -7.7% |
| 2006 | 0.36x | CN¥13.91 Million | CN¥38.50 Million | CN¥13.91 Million | — |